Preventing Type 2 Diabetes in Black Emergent Adult
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Feb 21, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying ways to prevent type 2 diabetes in Black women aged 18 to 25 who are at risk due to problems with binge eating. Type 2 diabetes is a serious condition that affects how your body uses sugar, and Black Americans are diagnosed at much higher rates than other groups. The trial focuses on reducing binge eating, which can lead to obesity and increase the risk of developing diabetes. Participants will need to be Black women within the specified age range, have a body mass index (BMI) of 25 or higher, experience binge eating episodes at least once a week, and be prediabetic.
If eligible, participants can expect to take part in activities designed to help them manage their eating habits and prevent weight gain. It's important to know that participants will need access to a smartphone and the internet to take part in the study. This research aims to address the higher risk of diabetes in young Black women by focusing on a behavior that can be changed, hopefully leading to better health outcomes.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Black women
- • between 18-25 years of age
- • BMI ≥ 25 kg/m\^2
- • At least one binge eating episode weekly
- • Prediabetic
- • Have access to a smartphone
- Exclusion Criteria:
- • Have no internet access
- • Currently type 2 diabetic
- • Currently pregnant
- • Are in substance use treatment
- • Have received prior or planned bariatric surgery
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Rachel Goode, PhD,MPH,LCSW
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported